A newly published study in the October 2010 issue of JADA confirms the safety and efficacy of a novel mucoadhesive patch method for controlling xerostomia, or dry mouth.
A new study being published in the journal Urology shows that Proantinox®, a proprietary cranberry-based blend used successfully in hospitals and long-term care facilities as UTI-Stat®, and now available directly to consumers as new Cystex® Liquid Cranberry Complex with Proantinox®, is safe and effective in significantly reducing the incidence of UTIs in women at risk for recurring infections.
Three recipients share $500,000 prize for their work on resolving the value of the Hubble constant, the key determinant for how fast the universe is expanding; July celebration to mark 10th anniversary of Gruber International Prize Program.
Jack Ansell, M.D., expert in hemostasis and thrombosis, Chairman of Medicine of Lenox Hill Hospital and founder of the Anticoagulation Forum, will be the keynote speaker of this online media Web cast, addressing this new CMS decision to expand coverage for INR self testing and the positive effects it will have on new pool of patients and their doctors.
Probiotic therapy has been clinically proven to assist in the prevention and management of antibiotic-associated diarrhea, but recent analysis concludes that only the yeast-based probiotic, Saccharomyces boulardii (S. boulardii is available under the brand name Florastor), combined with antibiotic therapy, is effective against the recurrence of the severe intestinal disease brought on by the Clostridium difficile (C. diff) pathogen.
For many college students, getting away from mom and dad may be great, but dorm-life also has its downfalls, including the foot fungus and wart-causing virus that can be picked up in communal bathrooms/showers. "Shared showers are one of the easier places to contract fungus and bacteria because the wet, steamy atmosphere is a great place for them to breed," explains Oliver Zong, D.P.M. popular New York City podiatrist and foot surgeon.
A new study shows that self-monitoring one's daily oral anticoagulation therapy can help heart patients reduce complications from the medication, and reduces the risk of death by one-third from all causes.
Sudden cardiac death is responsible for one-third of coronary artery disease in women, and the reason why women with heart disease and recurrent heart arrhythmias are prime candidates for implanted cardioverter defibrillators. New technology can monitor these devices remotely.